Skip to content

Anti Mi2 Dermatomyositis Cn378609

Published: July 22, 2026Updated: August 20, 2026

A type of inflammatory muscle disease with specific antibodies, causing muscle weakness and skin rash. Generally responds well to treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
M35.9
ICD-11
FA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Heliotrope rash

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Gottron papules

(musculoskeletal)

Proximal muscle weakness

(musculoskeletal)

Skin ulceration

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Glucocorticoid therapy

High-dose corticosteroids serve as first-line treatment for anti-Mi2 dermatomyositis to control muscle inflammation and skin manifestations. This condition typically shows favorable response to steroids compared to other dermatomyositis subtypes. Tapering protocols are individualized based on clinical response.

medication
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Steroid-sparing immunosuppressants

Agents such as methotrexate or azathioprine are introduced early to enable corticosteroid tapering and maintain remission. These medications provide long-term disease control with fewer steroid-related side effects. Regular monitoring of hematologic and hepatic parameters is required.

medication

Additional treatment options

Muscle rehabilitation program

Graduated exercise therapy prevents muscle atrophy and improves functional recovery. Physical therapy is introduced after acute inflammation subsides. Programs focus on strength building, endurance, and functional mobility.

physical_therapy

Sun protection and photavoidance

Strict sun protection including broad-spectrum sunscreen, protective clothing, and avoiding peak sun hours helps prevent dermatomyositis flares. UV exposure can trigger both skin and systemic manifestations. This is a critical lifestyle modification.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Mi2 Dermatomyositis Cn378609?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lundberg IE, Tjarnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies. Arthritis Rheumatol. 2017.

guideline2017
2

Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of inflammatory myopathies. J Clin Pathol. 2016.

review2016
3

Tiniakou E, Pinal-Fernandez I, Lloyd TE, et al. More severe disease and slower recovery in younger patients with anti-Mi-2 dermatomyositis. Rheumatology. 2020.

clinical_trial2020
4

Sarkozi R, Gelfand EW. Treatment of dermatomyositis and polymyositis. Curr Opin Rheumatol. 2022.

review2022

Medication Comparisons

Compare medications used to treat Anti Mi2 Dermatomyositis Cn378609. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy